U.S. Markets closed

Esperion Therapeutics, Inc. (ESPR)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
44.74-0.24 (-0.53%)
At close: 4:00PM EDT
People also watch
PTCTAGIOCLVSKITEBLUE
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development57,86829,80225,302
Selling General and Administrative18,28220,23810,922
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-76,150-50,040-36,224
Income from Continuing Operations
Total Other Income/Expenses Net1,548776119
Earnings Before Interest and Taxes-74,602-49,264-36,105
Interest Expense376520270
Income Before Tax-74,978-49,784-36,375
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-74,978-49,784-36,375
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-74,978-49,784-36,375
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-74,978-49,784-36,375